Plasma asymmetric dimethylarginine predicts restenosis after coronary angioplasty

INTRODUCTION: Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of endothelial nitric oxide synthase. Asymmetric dimethylarginine may influence the process of restenosis after coronary angioplasty. The aim of the study was to determine if initial plasma ADMA level could predi...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Derkacz, Arkadiusz, Protasiewicz, Marcin, Poręba, Rafał, Doroszko, Adrian, Poręba, Małgorzata, Antonowicz-Juchniewicz, Jolanta, Andrzejak, Ryszard, Szuba, Andrzej
Format: Artigo
Langue:Inglês
Publié: Termedia Publishing House 2011
Sujets:
Clinical Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3258748/
https://ncbi.nlm.nih.gov/pubmed/22295027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2011.23410
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires